ISRG Stock Price Today (September 2026) — Intuitive Surgical, Inc. Analysis & Key Metrics 2026-09-03
Intuitive Surgical, Inc. (ISRG) is trading at $369.83, down 0.55% today (as of September 2026). The stock continues to show pressure below major moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $478.01 (29.3% upside).
- Volatility remains elevated (26.02% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (18.50% YoY) alongside significant competitive pressures.
ISRG Stock Analysis: Key Metrics & Valuation (September 2026)
Concise, actionable data for investors
Intuitive Surgical, Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $126.54B
P/E Ratio
Forward P/E: 31.22
Revenue Growth
Year over Year
Analyst Target
+29.3% upside potential
Key Investor Questions About ISRG
What investors need to know before buying
Based on current market data, ISRG presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 43.77)
- Fundamentals say: Mixed signals (nuanced financial profile)
ISRG's growth trajectory depends on its ability to expand within the Medical Instruments & Supplies sector while managing margin pressures.
- Future growth will depend on performance in core Medical Instruments & Supplies operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for ISRG investors include debt exposure and competitive dynamics in the Medical Instruments & Supplies industry.
- $0 in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Medical Instruments & Supplies.
52-Week Trading Range
Over the past year, ISRG stock traded between $328.57 and $603.88—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 26.02% annualized volatility and β=1.14, the stock exhibits moderate correlation to market moves—making ISRG suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
ISRG Stock: The Best House On The Block Costs The Most
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium.
Intuitive Surgical's Worst Stretch in Years Isn't Scaring Wall Street -- Here's What Analysts Are Focused On Instead
The stock has dropped more than 30% this year.
Medtronic Tops Earnings Estimates and Makes $700M Robot Surgeon Investment. Is It Gaining on Intuitive Surgical?
Medtronic stock advances after the company posts better-than-expected quarterly earnings, raises revenue guidance, and announces a $700 million investment.
How Is Intuitive Surgical's Stock Performance Compared to Other Health Care Equipment Stocks?
Intuitive Surgical has notably underperformed the Health Care Equipment industry over the past year, but analysts are highly optimistic about the stock’s prospects.
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
Intuitive Surgical is boosting R&D despite macro headwinds, targeting AI, robotics and new procedures to expand its market and drive long-term growth.
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $372.6, indicating a +1.51% shift from the previous trading day.
Integra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can ISRG Stock Defend Its $131B Valuation?
This is a market-broadening year for Intuitive Surgical. The company is expanding beyond its core da Vinci systems to serve a wider continuum of hospitals and surgery centers.
Is Intuitive Surgical (ISRG) Below Fair Value After Strong Revenue And Procedure Growth?
Intuitive Surgical (ISRG) has been back in focus after reporting another quarter of double digit revenue and procedure growth, supported by adoption of its da Vinci 5, single port system and Ion lung biopsy platform. Despite the strong quarterly update, Intuitive Surgical’s share price has been under pressure, with the stock down 34.09% on a year to date share price return and down 21.38% on a 1-year total shareholder return. This contrasts with its 16.27% total shareholder return over three...
3 Healthcare Stocks with Promising Prospects
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 24.9% gain over the past six months, beating the S&P 500 by 13.3 percentage points.
Explore More Analysis for ISRG
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Frequently Asked Questions
Common investor questions about Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (ISRG) is currently trading at $369.83. The RSI (14-day) is at 43.8, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $478.01 implies 29.3% upside from current levels. Volatility is moderate at 26.0% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Intuitive Surgical, Inc. (ISRG): The trailing P/E ratio is 42.41, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 31.22, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.80, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 7.20. Price-to-Sales is 12.01. Valuation should be compared to Medical Instruments & Supplies industry peers for context, as different sectors trade at different multiples.
Based on 30 analysts covering ISRG, the consensus price target is $478.01. This represents a 29.3% upside from the current price of $369.83. The range spans from a low target of $324.00 to a high target of $685.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Intuitive Surgical, Inc. (ISRG) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Intuitive Surgical, Inc. (ISRG) investors include: 1. Moderate volatility (26.0% annualized)—price swings are notable. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Medical Instruments & Supplies sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Intuitive Surgical, Inc.'s (ISRG) current debt and financial health profile: Total debt stands at $0. The current ratio is 4.96, indicating strong short-term liquidity. The quick ratio is 3.64. The company holds $5.22B in cash and equivalents. Free cash flow is positive at $2.62B, providing a cushion for debt servicing and shareholder returns.